ChinaDaily Briefs

China: Hong Kong Hang Seng Index, Pinduoduo, Arrail Group, Alibaba Group, Jiangsu Recbio Technology, China Power International, Country Garden Holdings Co and more

In today’s briefing:

  • HSI Short for a Give Back
  • Pinduoduo (PDD): 4Q21, Undervalued Growth Rate and Record Profit Since IPO, Buy
  • Arrail Group (瑞尔集团) IPO Trading: Weak Demand, Rich Valuation
  • US Expansion of Travel Bans the First Step in Broader Escalation?
  • RecBio (江苏瑞科) IPO: Fairly Valued on Optimistic Industry Forecast
  • China Power International (2380 HK): Transformation to Soon Bear Fruits
  • Morning Views Asia: Country Garden Holdings Co, Fosun International, Sunac China Holdings

HSI Short for a Give Back

By Thomas Schroeder

  • HSI’s short squeeze spike is due for a pullback to the 20,200 to 19,700 support. We liked layering into a short near 21,700-22,500 for a pullback.
  • RSI kissed the ideal sell barrier. Sell volumes on a slip as well as buy volumes on a reaction rise will shed light on participation/repositioning.
  • Short for a pullback with a second trade to buy the sub 20k zone for a reaction rise.

Pinduoduo (PDD): 4Q21, Undervalued Growth Rate and Record Profit Since IPO, Buy

By Ming Lu

  • PDD’s total revenue growth was low 4Q21, as the company gave up on direct sales.
  • However, we believe the revenue growth will bounce back in 2023.
  • PDD cut sales and marketing expense, so we believe operating margin will improve in following two years.

Arrail Group (瑞尔集团) IPO Trading: Weak Demand, Rich Valuation

By Ke Yan, CFA, FRM

  • Arrail Group raised HKD 589.9 million (USD 75m) from its global offering and will list on the Hong Kong Stock Exchange on Tuesday, Mar 22nd.
  • In our previous notes, we looked at the company’s background, its operation, its financials, and its expansion plan, compared its key metrics with peers and provided thoughts on valuation.
  • In this note, we look at the updates since our last note and prior to debut.

US Expansion of Travel Bans the First Step in Broader Escalation?

By Mio Kato

  • The US just expanded travel bans against Chinese officials said to be repressing ethnic and religious minorities. 
  • The timing, a few days after a Biden-Xi call on Russia that appeared to achieve little of substance is telling. 
  • Noises out of the UK have been similarly aggressive here and the question now is how Europe responds.

RecBio (江苏瑞科) IPO: Fairly Valued on Optimistic Industry Forecast

By Ke Yan, CFA, FRM

  • RecBio is an innovative vaccine company with a focus on HPV vaccines. The company started book building to raise up to USD 98m via a Hong Kong listing.
  • In the previous note, we looked at the company’s core products, including its HPV portfolio and the COVID-19 vaccine and the valuation.
  • In this note, we provide an update for the book building. We will run the deal through our ECM framework and provide an update on the deal.

China Power International (2380 HK): Transformation to Soon Bear Fruits

By Osbert Tang, CFA

  • 2H21 is bad for China Power International (2380 HK) as coal price surged. But the positive news is that its wind and solar segments logged a 50.6% full-year profit growth.
  • There is good progress on transformation and it has 7GW of clean energy capacity to come on stream in FY22. This is equivalent to 46% of the existing capacity.
  • CPI said coal-fired plants are marginally profitable in Jan-Feb; meanwhile, hydropower will do better in this year. Overall, these set the stage for a turnaround.

Morning Views Asia: Country Garden Holdings Co, Fosun International, Sunac China Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma